Large-scale testing (Phase 3)Ended earlyNCT02505087
What this trial is testing
Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)
Who this might be right for
Selenoprotein N-related Myopathy
Assistance Publique - Hôpitaux de Paris 7